| Christopher William Urbanek, DO | |
|
334 Main St, Dickson City, PA 18519-1668 | |
| (570) 307-1767 | |
| Not Available |
| Full Name | Christopher William Urbanek |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Sports Medicine |
| Location | 334 Main St, Dickson City, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548608318 | NPI | - | NPPES |
| 19RMB | Other | NC | BCBS OF NC |
| 1548608318 | Medicaid | NC | |
| NCY927A | Other | NC | MEDICARE |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher William Urbanek, DO Po Box 751069, Charlotte, NC 28275-1069 Ph: () - | Christopher William Urbanek, DO 334 Main St, Dickson City, PA 18519-1668 Ph: (570) 307-1767 |
News Archive
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
Electroconvulsive therapy (ECT) has long had a stigma of being a painful and barbaric method of treatment, but a new study found that patients undergoing ECT for a variety of psychiatric disorders view the therapy in a positive light.
Each year more than 45,000 Americans suffer burns serious enough to require a hospital stay, according to the American Burn Association. While the traditional therapy of using skin grafts to cover burn sites has improved, a number of problems including scarring, infection and poor adhesion remain.
A recent study done by two Alliant faculty members suggests government funding for relationship counseling will ultimately save taxpayers money through reduced divorce rates.
Less than 9 months after implementing a new CRM application, Accera Pharmaceuticals began searching for a replacement. The commercial-stage biotechnology company, which launched Axona™ (a prescription-only medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease) around the same time as it implemented its current system, had quickly outgrown the generic CRM tool.
› Verified 9 days ago